CYP19A1 and breast carcinoma: The Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) exercise study aimed to compare the training effect expressed as the individual maximum power output in watt on a cycle ergometer and physical activity calculated as METh/week during unsupervised or supervised exercise training in breast cancer patients during aromatase inhibitor treatment.